Therapeutic Asset Ratings

278 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Dostarlimab Breast Neoplasm	QuantumLeap Healthcare Collaborative	P2	CCC (48)
Dostarlimab HER2 Positive Breast Carcinoma	QuantumLeap Healthcare Collaborative	P2	CCC (48)
Encequidar Breast Neoplasm	QuantumLeap Healthcare Collaborative	P2	CCC (48)
Encequidar Her2-Receptor Negative Breast Cancer	QuantumLeap Healthcare Collaborative	P2	CCC (48)
Encequidar HER2 Positive Breast Carcinoma	QuantumLeap Healthcare Collaborative	P2	CCC (48)
Fianlimab Breast Neoplasm	QuantumLeap Healthcare Collaborative	P2	CCC (48)
Fianlimab Her2-Receptor Negative Breast Cancer	QuantumLeap Healthcare Collaborative	P2	CCC (48)
Fianlimab HER2 Positive Breast Carcinoma	QuantumLeap Healthcare Collaborative	P2	CCC (48)
Gsk 5733584 Breast Neoplasm	QuantumLeap Healthcare Collaborative	P2	CCC (48)
Gsk 5733584 Her2-Receptor Negative Breast Cancer	QuantumLeap Healthcare Collaborative	P2	CCC (48)
Gsk 5733584 HER2 Positive Breast Carcinoma	QuantumLeap Healthcare Collaborative	P2	CCC (48)
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL REGN2810 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2810 .KAPPA.-CHAIN, DIMER Breast Neoplasm	QuantumLeap Healthcare Collaborative	P2	CCC (48)
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL REGN2810 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2810 .KAPPA.-CHAIN, DIMER Her2-Receptor Negative Breast Cancer	QuantumLeap Healthcare Collaborative	P2	CCC (48)
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL REGN2810 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2810 .KAPPA.-CHAIN, DIMER HER2 Positive Breast Carcinoma	QuantumLeap Healthcare Collaborative	P2	CCC (48)
IMMUNOGLOBULIN G, ANTI-(HUMAN INSULIN-LIKE GROWTH FACTOR I RECEPTOR) (HUMAN MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LIGHT CHAIN, DIMER Angiosarcoma	QuantumLeap Healthcare Collaborative	P2	CCC (48)
IMMUNOGLOBULIN G, ANTI-(HUMAN INSULIN-LIKE GROWTH FACTOR I RECEPTOR) (HUMAN MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LIGHT CHAIN, DIMER Hormone Receptor Negative Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (48)
IMMUNOGLOBULIN G, ANTI-(HUMAN INSULIN-LIKE GROWTH FACTOR I RECEPTOR) (HUMAN MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LIGHT CHAIN, DIMER Hormone Receptor Positive Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (48)
IMMUNOGLOBULIN G, ANTI-(HUMAN INSULIN-LIKE GROWTH FACTOR I RECEPTOR) (HUMAN MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LIGHT CHAIN, DIMER Triple-Negative Breast Carcinoma	QuantumLeap Healthcare Collaborative	P2	CCC (48)
Ladiratuzumab Vedotin Breast Neoplasm	QuantumLeap Healthcare Collaborative	P2	CCC (48)
Ladiratuzumab Vedotin Her2-Receptor Negative Breast Cancer	QuantumLeap Healthcare Collaborative	P2	CCC (48)
Lasofoxifene Breast Neoplasm	QuantumLeap Healthcare Collaborative	P2	CCC (48)
Lasofoxifene Her2-Receptor Negative Breast Cancer	QuantumLeap Healthcare Collaborative	P2	CCC (48)
Lasofoxifene HER2 Positive Breast Carcinoma	QuantumLeap Healthcare Collaborative	P2	CCC (48)
N-DESMETHYL-4-HYDROXYTAMOXIFEN HER2 Positive Breast Carcinoma	QuantumLeap Healthcare Collaborative	P2	CCC (48)
Pexidartinib Breast Neoplasm	QuantumLeap Healthcare Collaborative	P2	CCC (48)

Showing 151 to 175 of 278 assets

PreviousPage 7 of 12Next